Evidence map›Paper›PMID 40510180›Full record

ArticleBrain, behavior, & immunity - health2025

Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trial.

Anna Ubink, Marieke R Ten Tusscher, Hans J van der Vliet, Joeri A J Douma, Tanja D de Gruijl, Hetty Bontkes, Petra Bonnet, Diede van Ens, Willemijn Hobo, Harry Dolstra and 9 more

Abstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anna UbinkDepartment of Laboratory Medicine, Laboratory Medical Immunology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Marieke R Ten TusscherDepartment of Medical BioSciences, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Hans J van der VlietDepartment of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, Location Vrije Universiteit, De Boelelaan 1117, 1081, HV Amsterdam, the Netherlands.
Joeri A J DoumaDepartment of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934, AD Leeuwarden, the Netherlands.
Tanja D de GruijlDepartment of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, Location Vrije Universiteit, De Boelelaan 1117, 1081, HV Amsterdam, the Netherlands.
Hetty BontkesDepartment of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Section Medical Immunology, Amsterdam UMC, Meibergdreef 9, 1105, AZ Amsterdam, the Netherlands.
Petra BonnetDepartment of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Section Medical Immunology, Amsterdam UMC, Meibergdreef 9, 1105, AZ Amsterdam, the Netherlands.
Diede van EnsDepartment of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Willemijn HoboDepartment of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Harry DolstraDepartment of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Ellis BarbéDepartment of Pathology, Amsterdam UMC, Location Vrije Universiteit, De Boelelaan 1117, 1081, HV Amsterdam, the Netherlands.
Susanne van der VeldeDepartment of Surgery, Amsterdam UMC, Location Vrije Universiteit, De Boelelaan 1117, 1081, HV Amsterdam, the Netherlands.
Catharina Willemien Menke-van der Houven van OordtDepartment of Medical Oncology, Cancer Centre Amsterdam, Amsterdam UMC, Location Vrije Universiteit, De Boelelaan 1117, 1081, HV Amsterdam, the Netherlands.
Simone H C HavenithDepartment of Medical Oncology, Flevoziekenhuis, Hospitaalweg 1, 1315, RA Almere, the Netherlands.
Annemarie Conijn-MensinkDepartment of Medical Oncology, Zaans Medical Centre, Kon. Julianaplein 58, 1502, DV Zaandam, the Netherlands.
Annette A van ZweedenDepartment of Medical Oncology, Amstelland Hospital, Laan van de Helende Meesters 8, 1186, AM Amstelveen, the Netherlands.
Harm WestdorpDepartment of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Joannes F M JacobsDepartment of Laboratory Medicine, Laboratory Medical Immunology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.
Laurien M BuffartDepartment of Medical BioSciences, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525, GA Nijmegen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-clinical studies have shown that exercise can decrease tumour growth through mobilisation, activation, and increased tumour infiltration of natural killer (NK) and CD8

Indexed as

CancerChemotherapyExerciseImmune monitoring

Identifiers

PMID40510180
PMCPMC12159211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.